Clinical Trial Update: Promacta Pregnancy Registry

View source ↗

Summary

This update notes the completion of GlaxoSmithKline's Promacta (eltrombopag) pregnancy registry, which monitors pregnancy outcomes in women exposed to the drug …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopaenic, Idiopathic | Status: COMPLETED